CD4 and rheumatoid arthritis: A 2012 study focusing on the identification of biomarkers predictive for early rheumatoid arthritis (RA) has revealed a correlation between BCL3 expression by circulating T cells and disease, with BCL3 identified as one of twelve genes comprising a potential CD4+ T cell gene “signature” in RA patients [101].